Hot Pursuit     31-Dec-24
Aurobindo Pharma Ltd up for third straight session
Aurobindo Pharma Ltd is quoting at Rs 1336.4, up 2.93% on the day as on 12:49 IST on the NSE. The stock is up 23.72% in last one year as compared to a 8.53% jump in NIFTY and a 39.09% jump in the Nifty Pharma index.

Aurobindo Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1336.4, up 2.93% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.2% on the day, quoting at 23596.55078125. The Sensex is at 77995.46, down 0.32%. Aurobindo Pharma Ltd has gained around 6.51% in last one month.

Meanwhile, Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has gained around 4.45% in last one month and is currently quoting at 23241.15, up 0.9% on the day. The volume in the stock stood at 17.27 lakh shares today, compared to the daily average of 10.78 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 1344, up 2.67% on the day. Aurobindo Pharma Ltd is up 23.72% in last one year as compared to a 8.53% jump in NIFTY and a 39.09% jump in the Nifty Pharma index.

The PE of the stock is 36.83 based on TTM earnings ending September 24.

Previous News
  Auro Pharma Q3 PAT slides 10% YoY to Rs 846 crore
 ( Hot Pursuit - 07-Feb-25   12:47 )
  Aurobindo Pharma consolidated net profit declines 9.66% in the December 2024 quarter
 ( Results - Announcements 07-Feb-25   07:32 )
  Board of Aurobindo Pharma approves acquisition of 26% stake in a solar energy company
 ( Corporate News - 06-Feb-25   20:22 )
  Board of Aurobindo Pharma approves acquisition of 80% stake in Tergene Biotech
 ( Corporate News - 06-Feb-25   20:19 )
  Apitoria Pharma's Unit 2 completes USFDA inspection
 ( Corporate News - 28-Jan-25   12:15 )
  Aurobindo Pharma Ltd rises for third straight session
 ( Hot Pursuit - 20-Jan-25   13:06 )
  Aurobindo Pharma to table results
 ( Corporate News - 17-Jan-25   18:01 )
  Aurobindo Pharma Ltd slips for fifth straight session
 ( Hot Pursuit - 08-Jan-25   13:35 )
  Aurobindo Pharma Ltd up for third straight session
 ( Hot Pursuit - 31-Dec-24   13:05 )
  CuraTeQ Biologics receives UK MHRA approval for oncology biosimilar Bevqolva
 ( Corporate News - 23-Dec-24   16:13 )
  Auro Pharma gets UK MHRA nod for cancer drug
 ( Hot Pursuit - 21-Dec-24   15:20 )
Other Stories
  BLS Intl Q3 PAT climbs 47% YoY to Rs 128 cr in FY25
  11-Feb-25   15:49
  Prince Pipes slumps after reporting dismal Q3 results
  11-Feb-25   15:30
  Crisil jumps after Q4 PAT rises 6.9% YoY
  11-Feb-25   15:24
  Northern Spirits spurts after Q3 PAT zooms 110% YoY to Rs 9 crore
  11-Feb-25   15:14
  Keystone Realtors Q3 PAT rises to Rs 30 cr in FY25
  11-Feb-25   15:10
  Talbros Automotive Q3 PAT rises 5% YoY to Rs 24 cr
  11-Feb-25   15:03
  HBL Engineering Ltd leads losers in 'A' group
  11-Feb-25   15:00
  Welspun Investments & Commercials Ltd leads losers in 'B' group
  11-Feb-25   14:45
  Volumes soar at CRISIL Ltd counter
  11-Feb-25   14:30
  Cera Sanitaryware declines as Q3 PAT slips 10% YoY to Rs 46 cr
  11-Feb-25   14:30
Back Top